134 related articles for article (PubMed ID: 38262251)
41. Recombinant human TSH versus thyroid hormone withdrawal in adjuvant therapy with radioactive iodine of patients with papillary thyroid carcinoma and clinically apparent lymph node metastases not limited to the central compartment (cN1b).
Rosario PW; Mourão GF; Calsolari MR
Arch Endocrinol Metab; 2017; 61(2):167-172. PubMed ID: 28226001
[TBL] [Abstract][Full Text] [Related]
42. Effect of prophylactic central neck dissection following total thyroidectomy on surgical site wound infection, hematoma, and haemorrhage in subjects with clinically node-negative papillary thyroid carcinoma: A meta-analysis.
Jin L; Liu L; Wang J; Zhang L
Int Wound J; 2023 Feb; 20(2):251-260. PubMed ID: 35702946
[TBL] [Abstract][Full Text] [Related]
43. Individualized Follow-Up Strategy for Patients with an Indeterminate Response to Initial Therapy for Papillary Thyroid Carcinoma.
Oh HS; Ahn JH; Song E; Han JM; Kim WG; Kim TY; Kim WB; Shong YK; Jeon MJ
Thyroid; 2019 Feb; 29(2):209-215. PubMed ID: 30384812
[TBL] [Abstract][Full Text] [Related]
44. Frequent screening with serial neck ultrasound is more likely to identify false-positive abnormalities than clinically significant disease in the surveillance of intermediate risk papillary thyroid cancer patients without suspicious findings on follow-up ultrasound evaluation.
Peiling Yang S; Bach AM; Tuttle RM; Fish SA
J Clin Endocrinol Metab; 2015 Apr; 100(4):1561-7. PubMed ID: 25632970
[TBL] [Abstract][Full Text] [Related]
45. Hemithyroidectomy and ipsilateral central neck dissection for T1 low-risk papillary thyroid cancer: single-institution retrospective observational study.
Giordano D; Botti C; Piana S; Castellucci A; Frasoldati A; Zini M; Fornaciari M; Crocetta FM; Ghidini A
Eur J Endocrinol; 2022 Mar; 186(5):535-542. PubMed ID: 35230264
[TBL] [Abstract][Full Text] [Related]
46. The impact of completion thyroidectomy followed by radioactive iodine ablation for patients with lymph node recurrence of papillary thyroid carcinoma.
Saito Y; Matsuzu K; Sugino K; Takami H; Kitagawa W; Nagahama M; Ito K
Surgery; 2019 Sep; 166(3):342-348. PubMed ID: 31128851
[TBL] [Abstract][Full Text] [Related]
47. Disease outcomes and nodal recurrence in patients with papillary thyroid cancer and lateral neck nodal metastases.
O'Neill CJ; Coorough N; Lee JC; Clements J; Delbridge LW; Sippel R; Sywak MS; Chen H; Sidhu SB
ANZ J Surg; 2014 Apr; 84(4):240-4. PubMed ID: 23316684
[TBL] [Abstract][Full Text] [Related]
48. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
[TBL] [Abstract][Full Text] [Related]
49. Recurrence and Complications in Pediatric and Adolescent Papillary Thyroid Cancer in a High-Volume Practice.
Rubinstein JC; Herrick-Reynolds K; Dinauer C; Morotti R; Solomon D; Callender GG; Christison-Lagay ER
J Surg Res; 2020 May; 249():58-66. PubMed ID: 31923715
[TBL] [Abstract][Full Text] [Related]
50. Patient Age Is an Independent Risk Factor of Relapse of Differentiated Thyroid Carcinoma and Improves the Performance of the American Thyroid Association Stratification System.
Trimboli P; Piccardo A; Signore A; Valabrega S; Barnabei A; Santolamazza G; Di Paolo A; Stati V; Chiefari A; Vottari S; Simmaco M; Ferrarazzo G; Ceriani L; Appetecchia M; Giovanella L
Thyroid; 2020 May; 30(5):713-719. PubMed ID: 31973653
[No Abstract] [Full Text] [Related]
51. Papillary thyroid carcinoma presenting as a primary renal tumor with multiple pulmonary and bone metastases: a case report.
Gezer E; Selek A; Tarkun İ; Cantürk Z; Çetinarslan B
J Med Case Rep; 2019 Apr; 13(1):95. PubMed ID: 31003598
[TBL] [Abstract][Full Text] [Related]
52. Recurrence predictability by various staging systems in 283 patients after thyroidectomy and radioactive iodine treated for papillary thyroid carcinoma.
Yaniv D; Mizrachi A; Raz R; Tzelnick S; Feinmesser R; Hamzany Y; Vaisbuch Y; Hilly O
Clin Otolaryngol; 2019 Nov; 44(6):1147-1152. PubMed ID: 31437357
[No Abstract] [Full Text] [Related]
53. ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial.
Hartl D; Godbert Y; Carrat X; Bardet S; Lasne-Cardon A; Vera P; Ilies E; Zerdoud S; Sarini J; Zalzali M; La Manna L; Schneegans O; Kelly A; Kauffmann P; Rodien P; Brunaud L; Grunenwald S; Housseau E; Laghouati S; Bouvet N; Lecerf E; Hadoux J; Lamartina L; Schlumberger M; Borget I
Trials; 2023 Apr; 24(1):298. PubMed ID: 37118818
[TBL] [Abstract][Full Text] [Related]
54. Hemithyroidectomy in the Treatment of Papillary Thyroid Carcinoma: A Prospective Study of 300 Patients.
Islam MA; Mohammed T; Mamoon TB; Chowdhury NH; Khan SR; Rahman ML
Mymensingh Med J; 2022 Oct; 31(4):1013-1019. PubMed ID: 36189546
[TBL] [Abstract][Full Text] [Related]
55. Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American thyroid association and Latin American thyroid society risk of recurrence classification systems.
Pitoia F; Bueno F; Urciuoli C; Abelleira E; Cross G; Tuttle RM
Thyroid; 2013 Nov; 23(11):1401-7. PubMed ID: 23517313
[TBL] [Abstract][Full Text] [Related]
56. Predictors of thyroglobulin in the lymph nodes recurrence of papillary thyroid carcinoma undergoing total thyroidectomy.
Xing Z; Qiu Y; Li Z; Zhang L; Fei Y; Zhu J; Su A
BMC Surg; 2021 Jan; 21(1):53. PubMed ID: 33482804
[TBL] [Abstract][Full Text] [Related]
57. [Prospective therapy study in differentiated thyroid carcinoma].
Gemsenjäger E; Heitz P; Martina B
Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
[TBL] [Abstract][Full Text] [Related]
58. Clinicopathological features of recurrent papillary thyroid cancer.
Zhu J; Wang X; Zhang X; Li P; Hou H
Diagn Pathol; 2015 Jul; 10():96. PubMed ID: 26168921
[TBL] [Abstract][Full Text] [Related]
59. Case report: exceptionally rapid growth character of hobnail variant of papillary thyroid carcinoma: a report of four cases.
Ito Y; Hirokawa M; Hayashi T; Ota H; Oshita M; Kihara M; Miya A; Miyauchi A
Endocr J; 2020 Oct; 67(10):1047-1053. PubMed ID: 32554948
[TBL] [Abstract][Full Text] [Related]
60. The role of radioactive iodine in the management of patients with differentiated thyroid cancer - An oncologic surgical perspective.
Nixon IJ; Shah JP; Zafereo M; Simo RS; Hay ID; Suárez C; Zbären P; Rinaldo A; Sanabria A; Silver C; Mäkitie A; Vander Poorten V; Kowalski LP; Shaha AR; Randolph GW; Ferlito A
Eur J Surg Oncol; 2020 May; 46(5):754-762. PubMed ID: 31952928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
